New regulations require the Life Science sector to keep genetic and medical product data for decades and maintain its viability.
The medical research and pharmaceutical community is transforming our lives and our future through dedication to the advancement of knowledge and the discovery of new medicines and treatments for diseases. But the life sciences sector is particularly vulnerable to adversaries (including insiders) using cyber attacks to steal its intellectual property, degrade the integrity of its research and trial data, and interrupt the safe operation of its manufacturing and supply chains. Furthermore, new regulations require the Life Science sector to keep genetic and medical product data for decades and maintain its viability. STASH is a key partner to keep data securely stored and shared. Its unique authentication and encryption processes slash the risk of insider access to key data. STASH has developed trustworthy digital repository technology and processes to ensure the storage and retrieval of viable data for decades. STASH is an essential partner for the data integrity challenges of the Life Sciences sector.
- US-FDA requires medical product companies to retain all (100%) of physical/digital data and information of their medical products from discovery, manufacturing and distribution for the life of the product and two years after the last product is distributed. Other Nations have similar edicts.
- HHS-HIPAA is requiring electronic medical records be retained for the life of the patient.
- The Genetic Information Nondiscrimination Act of 2008 (GINA) is requiring that a patient’s genetic data be maintained for the life of the individual and 50 years after their death (for family use).